Upwork Reports First Quarter 2024 Financial Results
May 01, 2024 16:03 ET
|
Upwork Inc.
First-quarter GAAP Net Income of $18.4 million First-quarter GAAP Diluted EPS of $0.13 First-quarter Adjusted EBITDA of $33.3 million Raises revenue and Adjusted EBITDA outlook for 2024 ...
Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
May 01, 2024 16:01 ET
|
Journey Medical Corporation
SCOTTSDALE, Ariz., May 01, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses...
Monolithic Power Systems Announces Results for the First Quarter Ended March 31, 2024
May 01, 2024 16:01 ET
|
Monolithic Power Systems, Inc.
KIRKLAND, Wash., May 01, 2024 (GLOBE NEWSWIRE) -- Monolithic Power Systems, Inc. (“MPS”) (Nasdaq: MPWR), a fabless global company that provides high-performance, semiconductor-based power...
FormFactor, Inc. Reports 2024 First Quarter Results
May 01, 2024 16:01 ET
|
FormFactor, Inc.
LIVERMORE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- FormFactor, Inc. (Nasdaq: FORM) today announced its financial results for the first quarter of fiscal 2024 ended March 30, 2024. Quarterly...
Enovix Announces First Quarter 2024 Financial Results
May 01, 2024 16:01 ET
|
Enovix Corporation
FREMONT, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, announced today financial results for first quarter 2024,...
Enovix Reaches Development Agreement with a Leading Smartphone OEM
May 01, 2024 16:01 ET
|
Enovix Corporation
FREMONT, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, today announced it has reached a development agreement with...
LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024
May 01, 2024 16:01 ET
|
Lenz Therapeutics, Inc.
SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focused on developing the first...
Galecto Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab
May 01, 2024 16:01 ET
|
Galecto, Inc.
BOSTON, May 01, 2024 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and fibrosis, today announced...
NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 01, 2024 16:01 ET
|
NuCana plc
EDINBURGH, United Kingdom, May 01, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA), (“NuCana” or the “Company”), announced that it has received a written notification (the “Notification Letter”)...
Qorvo® Announces Fiscal 2024 Fourth Quarter Financial Results
May 01, 2024 16:00 ET
|
Qorvo, Inc.
GREENSBORO, N.C., May 01, 2024 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq:QRVO), a leading global provider of connectivity and power solutions, today announced financial results for the Company’s fiscal...